JuLib | Articles & more - {"Pathophysiological Mechanisms of Neurological and Psychiatric Diseases"}

1

Contribution to a conference proceedings
Journal Article

NI-19. The use of dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine-PET in the clinical evaluation of brain tumors in children and adolescents

Dunkl, Veronika
2014

Neuro-Oncology, 16 (2014) S. v138-v158

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

2

Journal Article

Isomers of 4-[18F]fluoro-proline: radiosynthesis, biological evaluation and results in humans using PET

Geisler, Stefanie
2014

Current radiopharmaceuticals, 7 (2014) S. 123-132

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

3

Contribution to a conference proceedings

F-18-FET PET IMAGING FOR DIAGNOSIS OF LATE PSEUDOPROGRESSION IN PATIENTS WITH HIGH-GRADE GLIOMAS

Kebir, S.
2014

2014

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

4

Conference Presentation

Diagnosis of Pseudoprogression in Patients with Glioblastoma Using Amino Acid PET.

Galldiks, N.
2014

2014

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

5

Conference Presentation

Differentiation of local recurrent brain metastasis from radiation-induced changes using O-(2-[18F]fluoroethyl)-L-tyrosine PET.

Galldiks, N.
2014

2014

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

6

Contribution to a conference proceedings
Journal Article

NI-37 * INCREASED CEREBRAL AMINO ACID UPTAKE DURING AND AFTER EPILEPTIC DISORDERS MIMICS BRAIN TUMOR IN 18F-FET PET

Hutterer, M.
2014

Neuro-Oncology, 16 (2014) suppl 5, S. v146 - v146

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

7

Journal Article

Letter to the Editor: “The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline” [J Neurooncol 2014; 11...

Langen, K. J.
2014

Journal of neuro-oncology, 120 (2014) 3, S. 665-666

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

8

Abstract

The use of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the diagnosis of patients with progressive and recurrent glioma.

Galldiks, N.
2014

2014

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

9

Journal Article

Comparison of $^{18}$F-FET PET and perfusion weighted MR imaging: a PET-MR imaging hybrid study in patients with brain tumors.

Filss, Christian
2014

Journal of Nuclear Medicine Journal of nuclear medicine, 55 55 (2014 2014) 4 4, S. 540-545 540-545

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

10

Journal Article

Relationship of Regional Cerebral Blood Flow and Kinetic Behaviour of O-(2-18F- Fluoroethyl)-L-Tyrosine Uptake in Cerebral Gliomas.

Zhang, Ke
2014

Nuclear medicine communications, 35 (2014) 3, S. 245–251

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

11

Contribution to a book

PET Imaging of Brain Tumors

Langen, Karl-Josef
2014

2014

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

12

Conference Presentation

The use of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the diagnosis of patients with progressive and recurrent glioma.

Galldiks, N.
2014

2014

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

13

Journal Article

Detection of remote neuronal reactions in the Thalamus and Hippocampus induced by rat glioma using the PET tracer cis-4-[(18)F]fluoro-D-proline.

Geisler, Stefanie
2013

Journal of cerebral blood flow & metabolism, 33 (2013) S. 724–731

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

14

Conference Presentation

The use of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the clinical evaluation of brain tumors in children and young adults.

Dunkl, Veronika
2013

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

15

Conference Presentation

Stellenwert der kinetischen O-(2-18F-Fluoroethyl)-L-Tyrosin PET bei Patienten mit sekundärer Malignisierung niedriggradiger Gliome.

Galldiks, Norbert
2013

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

16

Journal Article

Reply: Discriminating Ability of $^{18}$ F-FET PET for Several Cerebral Neoplastic Lesions

Langen, K. -J.
2014

Journal of Nuclear Medicine Journal of nuclear medicine, 55 55 (2013 2013) 1 1, S. 176-176 176-176

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

17

Poster

Role of [18F]fluoroethyl-L-tyrosine PET as diagnostic tool for malignant transformation in patients with low-grade glioma.

Galldiks, Norbert
2013

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

18

Conference Presentation

Stellenwert der kinetischen O-(2-18F-Fluoroethyl)-L-Tyrosin PET bei Patienten mit sekundärer Malignisierung niedriggradiger Gliome.

Galldiks, Norbert
2013

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

19

Contribution to a conference proceedings

The use of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.

Galldiks, Norbert
2013

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

20

Poster

The use of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.

Galldiks, Norbert
2013

“...Pathophysiological Mechanisms of Neurological and Psychiatric Diseases...”

Narrow Search Results